Solid Tumor Malignancies
36
20
21
4
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.1%
4 terminated out of 36 trials
50.0%
-36.5% vs benchmark
6%
2 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (36)
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies
xDRIVE for Florida-based Cancer Patients
ALI Post Radiation Therapy in Patients With Lung and Esophageal Canter
ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors.
Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
Study of ZE94-0605 in Patients With Advanced Solid Tumors, With Dose Expansion Cohorts.
CSF and Blood Plasma Liquid Biopsy in Patients With Metastatic Solid Tumours and CNS Metastases or no CNS Metastases
Exploration Study of Molecular Biomarkers for Tumor-related Anxiety and Depression
Predicting Reactions and Effects of Drugs Immunotherapy and Complications Through Oncosafety (PREDICTO Clinical Study)
A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
A Study of SH009 Injection in Patients With Advanced Solid Tumors.
A Phase I First-in-Human Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-Tumor Activity of SWA1211 Tablets in Subjects With Advanced Solid Tumors
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
Malic Acid Supplementation Combined With Immunotherapy in Patients With Solid Tumors
Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors